Ocugen is trading at MXN 14.01, down 6.60%, with no clear company-specific catalyst identified in available coverage.

  • U.S. markets were lower, including the Nasdaq Composite, down 1.60%; broader risk-off sentiment may be contributing.
  • Ocugen announced November conference appearances on October 29, but the release does not establish a connection to the decline.
  • Trading volume or activity for the Mexican listing was not verified.